Table 1 Relationship between expression of GSDMD and CASP1/4/5 and statistically significant clinical characteristics of patients
Clinical characteristics | n | GSDMD | Casp1 | Casp4 | Casp5 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
2-ΔΔct | P | 2-ΔΔct | P | 2-ΔΔct | P | 2-ΔΔct | P | |||
Tumor diameter | ≤ 5 cm > 5 cm | 36 35 | 1.283 ± 0.356 1.508 ± 0.267 | 0.361 | 0.836 ± 0.397 0.294 ± 0.175 | 0.029 | 1.692 ± 0.735 1.420 ± 0.816 | 0.620 | 1.209 ± 0.512 0.773 ± 0.401 | 0.031 |
Lymph node involvement | Yes No | 40 31 | 1.730 ± 1.106 1.349 ± 0.976 | 0.030 | 0.842 ± 0.351 0.436 ± 0.238 | 0.764 | 1.934 ± 1.067 1.306 ± 1.052 | 0.023 | 1.356 ± 0.842 0.730 ± 0.514 | 0.327 |